BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 8909525)

  • 1. Impairment of endothelial-dependent pulmonary vasorelaxation after mesenteric ischemia/reperfusion.
    Fullerton DA; Eisenach JH; Friese RS; Agrafojo J; Sheridan BC; McIntyre RC
    Surgery; 1996 Nov; 120(5):879-84. PubMed ID: 8909525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhaled nitric oxide prevents pulmonary endothelial dysfunction after mesenteric ischemia-reperfusion.
    Fullerton DA; Eisenach JH; McIntyre RC; Friese RS; Sheridan BC; Roe GB; Agrafojo J; Banerjee A; Harken AH
    Am J Physiol; 1996 Aug; 271(2 Pt 1):L326-31. PubMed ID: 8770072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endotoxin stuns cGMP-mediated pulmonary vasorelaxation.
    Sheridan BC; McIntyre RC; Meldrum DR; Meng X; Fullerton DA
    Shock; 1997 Sep; 8(3):207-12. PubMed ID: 9377168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. L-arginine attenuates endothelial dysfunction in endotoxin-induced lung injury.
    Sheridan BC; McIntyre RC; Meldrum DR; Fullerton DA
    Surgery; 1999 Jan; 125(1):33-40. PubMed ID: 9889795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neutrophil depletion attenuates endotoxin-induced dysfunction of cGMP-mediated pulmonary vasorelaxation.
    Sheridan BC; McIntyre RC; Agrafojo J; Meldrum DR; Meng X; Fullerton DA
    Am J Physiol; 1996 Nov; 271(5 Pt 1):L820-8. PubMed ID: 8944726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dysfunction of cGMP-mediated pulmonary vasorelaxation in endotoxin-induced acute lung injury.
    Fullerton DA; McIntyre RC; Hahn AR; Agrafojo J; Koike K; Meng X; Banerjee A; Harken AH
    Am J Physiol; 1995 Jun; 268(6 Pt 1):L1029-35. PubMed ID: 7611425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. L-arginine prevents lung neutrophil accumulation and preserves pulmonary endothelial function after endotoxin.
    Sheridan BC; McIntyre RC; Meldrum DR; Fullerton DA
    Am J Physiol; 1998 Mar; 274(3):L337-42. PubMed ID: 9530168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NO prevents neutrophil-mediated pulmonary vasomotor dysfunction in acute lung injury.
    Friese RS; Fullerton DA; McIntyre RC; Rehring TF; Agrafojo J; Banerjee A; Harken AH
    J Surg Res; 1996 Jun; 63(1):23-8. PubMed ID: 8661166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neutrophils mediate pulmonary vasomotor dysfunction in endotoxin-induced acute lung injury.
    Sheridan BC; McIntyre RC; Moore EE; Meldrum DR; Agrafojo J; Fullerton DA
    J Trauma; 1997 Mar; 42(3):391-6; discussion 396-7. PubMed ID: 9095105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intracellular mechanisms of pulmonary vasomotor dysfunction in acute lung injury caused by mesenteric ischemia-reperfusion.
    Fullerton DA; Hahn AR; Koike K; Banerjee A; Harken AH
    Surgery; 1993 Aug; 114(2):360-6; discussion 366-7. PubMed ID: 8393598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanistic imbalance of pulmonary vasomotor control in progressive lung injury.
    Fullerton DA; Hahn AR; McIntyre RC
    Surgery; 1996 Jan; 119(1):98-103. PubMed ID: 8560394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pulmonary vasomotor dysfunction is produced with chronically high pulmonary blood flow.
    Fullerton DA; Mitchell MB; Jones DN; Maki A; McIntyre RC
    J Thorac Cardiovasc Surg; 1996 Jan; 111(1):190-7. PubMed ID: 8551766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective inhibition of cyclic adenosine monophosphate-mediated pulmonary vasodilation by acute hypoxia.
    McIntyre RC; Banerjee A; Hahn AR; Agrafojo J; Fullerton DA
    Surgery; 1995 Mar; 117(3):314-8. PubMed ID: 7878538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibody-mediated neutrophil depletion preserves pulmonary vasomotor function.
    Sheridan BC; McIntyre RC; Meldrum DR; Cleveland JC; Agrafojo J; Eisenach JH; Harken AH; Fullerton DA
    J Surg Res; 1996 Apr; 62(1):74-8. PubMed ID: 8606514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vinblastine attenuates endotoxin-induced impairment of CGMP-mediated pulmonary vasorelaxation.
    Sheridan BC; McIntyre RC; Meldrum DR; Cleveland JC; Agrafojo J; Eisenach JH; Fullerton DA
    Shock; 1996 Jul; 6(1):35-8. PubMed ID: 8828082
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cold ischemia and reperfusion each produce pulmonary vasomotor dysfunction in the transplanted lung.
    Fullerton DA; Mitchell MB; McIntyre RC; Banerjee A; Campbell DN; Harken AH; Grover FL
    J Thorac Cardiovasc Surg; 1993 Dec; 106(6):1213-7. PubMed ID: 8246563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endotoxin differentially impairs cyclic guanosine monophosphate-mediated relaxation in the pulmonary and systemic circulations.
    McIntyre RC; Sheridan B; Agrafojo J; Fullerton DA
    Crit Care Med; 1997 Feb; 25(2):318-23. PubMed ID: 9034271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phosphodiesterase inhibition overcomes pulmonary vasomotor dysfunction in acute lung injury.
    Sheridan BC; McIntyre RC; Meldrum DR; Fullerton DA
    J Surg Res; 1997 Aug; 71(2):145-9. PubMed ID: 9299282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. KATP channels contribute to beta- and adenosine receptor-mediated pulmonary vasorelaxation.
    Sheridan BC; McIntyre RC; Meldrum DR; Fullerton DA
    Am J Physiol; 1997 Nov; 273(5):L950-6. PubMed ID: 9374721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Indigo carmine inhibits endothelium-dependent and -independent vasodilation.
    Chang KS; Zhong MZ; Davis RF
    Hypertension; 1996 Feb; 27(2):228-34. PubMed ID: 8567045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.